key: cord-0963291-eug094xk authors: Weitzel, Thomas; Legarraga, Paulette; Iruretagoyena, Mirentxu; Pizarro, Gabriel; Vollrath, Valeska; Porte, Lorena; Araos, Rafael; Munita, José M. title: Comparative evaluation of four rapid SARS-CoV-2 antigen detection tests using universal transport medium date: 2020-12-02 journal: Travel Med Infect Dis DOI: 10.1016/j.tmaid.2020.101942 sha: 860c4a74d6ea0b6c6569aac8baf2050c22ab266f doc_id: 963291 cord_uid: eug094xk nan The containment of the ongoing COVID-19 pandemic requires reliable detection of COVID-19 cases, currently done by real-time reverse-transcription polymerase chain reaction (RT-PCR) [1] . The gap between the number of samples and laboratory capacities to perform RT-PCR in a timely manner, however, is a major limitation of the public health response to COVID-19 [1] . Therefore, there is a critical demand for alternative detection methods, especially rapid diagnostic tests (RDTs), which due to their ease of use might serve as point-of-care tests in community-based settings [2] . Antibody detection tests for SARS-CoV-2 are limited by the delay in humoral immune response, whereas newly developed assays targeting viral antigens have the potential for early diagnosis [2] . However, the accuracy and real-world performance of such assays is unknown and their validation is therefore of high priority [2] . Here we present a head-to-head comparison of four novel antigen-based RDTs for the detection of SARS-CoV-2 from respiratory specimens. Two of the evaluated assays were based on classical immunochromatography and two used immunofluorescence (Table 1) . Noteworthy, the test protocol deviated from manufacturer´s instructions by using an equivalent volume of UTM (instead of the recommended test buffer), as previously described [3, 4] . Samples were selected by convenience among the 5,276 respiratory specimens processed for SARS-CoV-2 during the study period. Due to the shortage of test kits, a 2:1 distribution of positive to negative samples was chosen. Seventeen positive specimens had been used in a previous evaluation [3] . Assays were tested in parallel from the same sample, performed under BSL2 conditions by the same trained technician, who was blinded to RT-PCR results. Assays with visual output were read by two independent observers, conferring with a third in case of disagreement. RT-PCR served as reference method; for samples with discordant result, tests were repeated. Demographic and clinical data were obtained from mandatory notification forms and analysed anonymously. Samples with high viral loads (Ct value ≤25) were compared to those with low viral load (Ct values >25), as previously described [4] . Statistical analysis considered sensitivity, specificity, accuracy, and Kappa coefficient using standard formulas, and Wilson score Confidence Interval at 95% (OpenEpi version 3.01, GraphPad Prism version 8.4.2). Study materials were purchased with laboratory funds, except for Savant RDT, which was provided free-of-charge through a local provider. The study was approved by the institutional review board (Comité Ético Científico, Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile) and need for informed consent was waived. The study included a total of 111 samples from symptomatic patients; 55% were female, with a median age of 40 years. Eighty specimens were RT-PCR positive, representing 22% of all positives during the study period; 31 samples were RT-PCR negative. The median duration from symptom onset to sampling was 2 days (IQR 1-5 days); 88% of specimens (96/109; missing data, J o u r n a l P r e -p r o o f n=2) were taken during the first week of symptoms. Ct values ranged from 10.7 to 37.7 (mean, 22.5). Test performances showed significant differences ( Table 1 ). The evaluation of the Liming Bio kit was stopped after 19 samples, due to its poor results. The other three assays had sensitivities ranging from 16.7% (Savant) to 85% (Bioeasy) and a specificity of 100%. Sensitivities were significantly higher in specimens with high viral loads (Ct values ≤25) for RapiGen (84.9%) and Bioeasy (100%) ( Table 1) . Concordance between these two tests was 82%, while their agreement with Savant was 67% and 50%, respectively. The visual readout of RapiGen was clear, regardless of the intensity of bands. The interpretation of Savant, requiring a UV flashlight provided by the manufacturer, was difficult; its sensitivity might have been higher using an automated reader. Bioeasy cassettes were interpreted by a desktop instrument with options for QR coding, printing, connectivity to laboratory information systems. Overall, the three systems were easy to use and gave a qualitative result in 10-20 minutes. Although our study directly compared the assays from the same sample material, the offlabel use of UTM might have influenced test results. However, some of the assays showed favourable overall sensitivities, suggesting the potential use of antigen-based RDTs as alternative (or adjunct) tools to RT-PCR. As in other studies [3, 5] , the performance was significantly higher in specimens with high viral loads (Ct ≤25). Since culture studies have shown a significant reduction of infectivity with low viral counts (Ct >24) [6] , antigen testing might play a crucial role within strategies aiming to determine the contagiousness of infected individuals. In conclusion, the study demonstrated a significant heterogeneity of test performance, which might have been influenced by the use of UTM as a non-validated sample material. The results emphasize that rapid antigen detection has the potential to serve as an alternative J o u r n a l P r e -p r o o f diagnostic method, especially as a screening tool for patients with high viral loads during early and infective stages of infection. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. There is no conflict of interest. J o u r n a l P r e -p r o o f Laboratory testing strategy recommendations for COVID-19 Advice on the use of point-of-care immunodiagnostic tests for COVID-19 Evaluation of novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples Development and potential usefulness of the COVID-19 Ag Respi-Strip diagnostic assay in a pandemic context Diagnosis of acute respiratory syndrome coronavirus 2 infection by detection of nucleocapsid protein Predicting infectious SARS-CoV-2 from diagnostic samples We thank Sabine Dittrich (FIND, Geneva) for the critical review of the manuscript.